Literature DB >> 3930834

[Thyroid hormones in women with liver cirrhosis].

R Grün, H Kaffarnik.   

Abstract

Basal thyroid hormone levels were measured in 68 women with liver cirrhosis (LC) of different etiology (alcoholic n = 34, posthepatitic B n = 9, PBC n = 5, cryptogenetic n = 18, M. Wilson n = 2). In addition the rise of TSH after 400 micrograms TRH was measured in 23 women with LC and compared with the data obtained from 17 women of a control group. There was no difference of the median T4-concentrations (LC 8.0 micrograms/dl versus 7.2 micrograms/dl) but a significant correlation of T4 to the grade of decompensation of LC. In contrast of T4 there was a marked decrease of T3 in LC-patients (109 ng/dl versus 143 ng/dl) and a rise of reverse T3 (0.21 ng/ml versus 0.13 ng/ml). The decrease of T3 and rise of reverse T3 equally correlated to the severeness of LC. TBG concentrations fell according to the grade of decompensation of LC and T4/TBG-quotient exhibited no difference to the control data (0.51 both). Though basal thyroid hormones and TSH show euthyroidism the significant augmented TSH release after TRH (delta-TSH 7.0 versus 3.2 microU/ml) indicate a status of latent hypothyroidism. In alcoholic cirrhosis the degree of TSH release was much higher than in non alcoholic cirrhosis. Estradiol and estrone levels correlated significantly negatively to T4, T3, estrone negatively to TBG and positively to reverse T3 but not to TSH and TSH release. Otherwise TSH release correlated positively to estradiol. The thyroid status in women with liver cirrhosis does not differ from the thyroid hormone profile found in men with cirrhosis.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3930834     DOI: 10.1007/bf01733827

Source DB:  PubMed          Journal:  Klin Wochenschr        ISSN: 0023-2173


  34 in total

1.  Thyroid function and thyroid regulation in euthyroid men with chronic liver disease: evidence of multiple abnormalities.

Authors:  J R Green; E J Snitcher; N A Mowat; R P Ekins; L H Rees; A M Dawson
Journal:  Clin Endocrinol (Oxf)       Date:  1977-12       Impact factor: 3.478

2.  An evaluation of factors which affect circulating thyroid hormone levels in liver diseases.

Authors:  Y Iwasaki; H Satoh; H Ikeda; H Uchimura; A Ohkubo; S Nagataki
Journal:  Kaku Igaku       Date:  1981-06

3.  Thyroid status in patients with alcoholic liver disease.

Authors:  S K Majumdar; G K Shaw; P O'Gorman; E J Aps; A D Thomson
Journal:  Drug Alcohol Depend       Date:  1981-07       Impact factor: 4.492

4.  Letter: Reverse triiodothyronine in liver disease.

Authors:  R Kodding; J Janzen; E Schmidt; R D Hesch
Journal:  Lancet       Date:  1976-08-07       Impact factor: 79.321

5.  Thyrotropin response to thyrotropin releasing hormone in normal females over forty.

Authors:  P J Snyder; R D Utiger
Journal:  J Clin Endocrinol Metab       Date:  1972-06       Impact factor: 5.958

6.  A study of extrathyroidal conversion of thyroxine (T4) to 3,3',5-triiodothyronine (T3) in vitro.

Authors:  I J Chopra
Journal:  Endocrinology       Date:  1977-08       Impact factor: 4.736

7.  Serum thyroid hormone levels in patients with liver disease.

Authors:  G W Hepner; I J Chopra
Journal:  Arch Intern Med       Date:  1979-10

8.  Thyroid hormone metabolism in patients with liver cirrhosis, as judged by urinary excretion of triiodothyronine.

Authors:  T Aizawa; T Yamada; M Tawata; T Shimizu; S Furuta; K Kiyosawa; M Yakata
Journal:  J Am Geriatr Soc       Date:  1980-11       Impact factor: 5.562

9.  Effects of chronic alcoholism on the pituitary-gonadal function of women during menopausal transition and in the post menopausal period.

Authors:  J N Hugues; G Perret; G Adessi; T Coste; E Modigliani
Journal:  Biomedicine       Date:  1978-11

10.  Kinetic studies of thyroxine, 3,5,3'-triiodothyronine, 3,3,5'-triiodothyronine, 3',5'-diiodothyronine, 3,3'-diiodothyronine, and 3'-monoiodothyronine in patients with liver cirrhosis.

Authors:  J Faber; H F Thomsen; I B Lumholtz; C Kirkegaard; K Siersbaek-Nielsen; T Friis
Journal:  J Clin Endocrinol Metab       Date:  1981-11       Impact factor: 5.958

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.